How Red Blood Cells Get Their Dimples

Myosin proteins tug on the cell membrane, giving an erythrocyte its distinct shape.

Sep 1, 2018
Ashley Yeager
IN A PINCH: In healthy red blood cells (RBCs), myosin fibers (blue) contract, pulling on actin (pink) and spectrin proteins (purple) connected to the cell membrane and helping to give the cells their distinct, indented shape (top). When the myosin fiber is experimentally manipulated so that it slackens or detaches from the cell-membrane proteins, red blood cells instead take on an oval shape (bottom). See full infographic: WEB | PDF
© kimberly battista


The paper

A.S. Smith et al., “Myosin IIA interacts with the spectrin-actin membrane skeleton to control red blood cell membrane curvature and deformability,” PNAS, 115:E4377–85, 2018.

Healthy red blood cells are puffy with a dimpled middle. “It’s just a really cool shape,” says Velia Fowler, a cell biologist at The Scripps Research Institute in San Diego. For decades, researchers have been wondering what gives red blood cells their characteristic curves, and now Fowler and her colleagues have the answer: myosin proteins tug on the red blood cell’s cytoskeletal membrane, creating a divot at the center.

Back in the 1980s, when Fowler started working with red blood cells, it wasn’t clear whether they even contained myosin. She suspected they might, because the protein appeared to play a role in giving other cells their shapes. After painstaking experiments, Fowler finally showed that red blood cells do carry the protein, but exactly how it influenced erythrocytes’ shape remained a mystery. “We didn’t have the tools to do those experiments then,” she says. The myosin filaments in red blood cells are tiny, only around 200 to 450 nanometers long, making them extremely challenging to image. And the first inhibitor of myosin IIA—the specific protein found in red blood cells—wasn’t developed until the early 2000s, so scientists couldn’t see what happened when the protein wasn’t functioning in the cells.

In the new study, the team attached an immunofluorescent tag to myosin and a phalloidin tag to actin in human red blood cells and observed the cells with both superresolution and total internal reflection fluorescence microscopy. Filaments of myosin attach to filaments of actin and the scaffolding protein spectrin that lie just beneath and parallel to the cell membrane, the team found. When myosin and actin interact and myosin contracts, the cell membrane stiffens, giving the cell a dimple at its center. Inhibiting the motor activity of the protein causes the myosin filaments to expand so they no longer tug on spectrin and actin. That leads to less tension in the membrane and, ultimately, the disappearance of the dimple.

By expanding and contracting, the myosin filaments likely make it possible for red blood cells to shape-shift as they tumble in the bloodstream’s shear flow and squeeze through microvessels such as capillaries, then pop back into their dimpled form, Fowler says.

This discovery could also give clues to how myosin works in other types of cells, Vann Bennett, a biochemist at Duke University who was not involved in the new study, tells The Scientist. “Red blood cells are a true experiment of nature,” he says. “They’ve gotten rid of the cell nucleus, mitochondria, and all cytoskeletal proteins.” These simplified cells “have been a powerhouse for generating concepts about how [plasma] membranes are organized in other cell types,” Bennett explains. Understanding the importance of myosin’s contraction in shaping red blood cells, he says, may help in teasing out its functions in other cell types.

Another recent study supports myosin’s widespread importance in maintaining cell structure: the research showed the protein is critical for axons to grow and shape themselves, suggesting it could be involved in brain plasticity (Neuron, 97:P555–70.E6, 2018).

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!